European Archives - Page 183 of 1279 - European Medical Journal

5 minutes with... Dr Tami Nussbaum, Takeda

Dr Tami Nussbaum, shares why she left medicine for pharma, the challenges of rare disease and how she avoids burnout.

Which Biologic is Best for Psoriasis Treatment?

A recent clinical trial has compared the effectiveness of IL-17 and IL-23 biologics in treating moderate to severe plaque psoriasis.

Intensive Blood Pressure Control Cuts Dementia Risk by 15%

Blood pressure control over 48 months cuts dementia risk by 15% in a large clinical trial.

Intraoperative Urine Output Similar with Volatile and IV Anaesthesia

Volatile anaesthetics and propofol show no significant difference in intraoperative urine output, study suggests.

Nasal Epithelial Assays Predict Cystic Fibrosis Clinical Outcomes

A new study supports the clinical utility of human nasal epithelial cultures as predictive biomarkers for cystic fibrosis CFTR modulator therapy.

Advanced CT Interpretation Aids Treatment Planning in MSI-H Colon Cancer

CT pattern analysis improves diagnosis and predicts immunotherapy success in MSI-H colon cancer. Read more!

Greater Metformin Use May Increase Risk of Diabetic Neuropathy

Study links metformin use to increased diabetic neuropathy risk in dose-dependent fashion.

Combining Acupuncture and Herbal Remedies for Urticaria

The results suggest that Wendan Decoction and acupuncture into treatment plans may enhance clinical outcomes for patients with urticaria.

Digital Exercise Intervention Boosts Livery Surgery Recovery

A recent study highlighted the potential benefits of digital health interventions in improving physical recovery for patients with primary liver cancer.

Reduced Mepolizumab Dose Effective for Long-Term EGPA Control

New findings show that eosinophilic granulomatosis with polyangiitis (EGPA) patients in remission may safely reduce mepolizumab dosage, potentially easing long-term treatment burden.